J. M. V. Mooij

593 total citations
28 papers, 460 citations indexed

About

J. M. V. Mooij is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, J. M. V. Mooij has authored 28 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 3 papers in Epidemiology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in J. M. V. Mooij's work include Blood Pressure and Hypertension Studies (5 papers), Cardiovascular Health and Disease Prevention (3 papers) and Pregnancy and preeclampsia studies (2 papers). J. M. V. Mooij is often cited by papers focused on Blood Pressure and Hypertension Studies (5 papers), Cardiovascular Health and Disease Prevention (3 papers) and Pregnancy and preeclampsia studies (2 papers). J. M. V. Mooij collaborates with scholars based in Saudi Arabia and Netherlands. J. M. V. Mooij's co-authors include Haysam Roujouleh, Marleen A. van Baak, Paul Schiffers, L.M.A.B. Van Bortel, J. A. Kragten, Tiny Van Merode, Hanneke Joosten, Hussein A. Elsayed, K. H. Rahn and Robert S. Reneman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Applied Physiology and Clinical Pharmacology & Therapeutics.

In The Last Decade

J. M. V. Mooij

28 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. M. V. Mooij Saudi Arabia 11 157 146 138 114 44 28 460
Adam Rahman Canada 11 239 1.5× 264 1.8× 65 0.5× 103 0.9× 36 0.8× 25 1.0k
László Asztalos Hungary 15 59 0.4× 178 1.2× 30 0.2× 110 1.0× 16 0.4× 60 622
L. R. Solomon United Kingdom 14 90 0.6× 73 0.5× 45 0.3× 108 0.9× 20 0.5× 35 615
Elliott Savdie Australia 15 79 0.5× 202 1.4× 36 0.3× 84 0.7× 22 0.5× 30 615
Robert B. Dorman United States 17 82 0.5× 491 3.4× 71 0.5× 75 0.7× 42 1.0× 25 810
Gilad Hamdani United States 13 44 0.3× 94 0.6× 38 0.3× 228 2.0× 31 0.7× 29 459
Daad H. Akbar Saudi Arabia 15 204 1.3× 56 0.4× 74 0.5× 53 0.5× 16 0.4× 42 619
Shinobu Sugihara Japan 7 53 0.3× 95 0.7× 28 0.2× 149 1.3× 14 0.3× 12 490
Joana Silvestre Portugal 12 263 1.7× 98 0.7× 39 0.3× 59 0.5× 25 0.6× 23 474
Duff Jh Canada 13 119 0.8× 261 1.8× 21 0.2× 67 0.6× 47 1.1× 29 522

Countries citing papers authored by J. M. V. Mooij

Since Specialization
Citations

This map shows the geographic impact of J. M. V. Mooij's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. M. V. Mooij with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. M. V. Mooij more than expected).

Fields of papers citing papers by J. M. V. Mooij

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. M. V. Mooij. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. M. V. Mooij. The network helps show where J. M. V. Mooij may publish in the future.

Co-authorship network of co-authors of J. M. V. Mooij

This figure shows the co-authorship network connecting the top 25 collaborators of J. M. V. Mooij. A scholar is included among the top collaborators of J. M. V. Mooij based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. M. V. Mooij. J. M. V. Mooij is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mooij, J. M. V., et al.. (2007). The impact of polymerase chain reaction assays for the detection of hepatitis C virus infection in a hemodialysis unit.. PubMed. 18(1). 107–13. 19 indexed citations
2.
Journée, H. L., Eelco W. Hoving, & J. M. V. Mooij. (2006). P27.4 Stimulation threshold–age relationship and improvement of muscle potentials by preconditioning transcranial stimulation in young children. Clinical Neurophysiology. 117. 115–115. 7 indexed citations
3.
Mooij, J. M. V., et al.. (2004). Cardiac troponin‐I and its prognostic significance in a dialysis population. Hemodialysis International. 8(4). 332–337. 9 indexed citations
4.
Mooij, J. M. V., et al.. (2003). Cerebral lupus in patients whilst on treatment for lupus nephritis with cyclosporine. Journal of Clinical Neuroscience. 10(1). 104–106. 2 indexed citations
5.
Mooij, J. M. V., et al.. (2003). Tuberculosis and Chronic Renal Disease. Seminars in Dialysis. 16(1). 38–44. 159 indexed citations
6.
Mooij, J. M. V., et al.. (2001). Factor Analysis, Including Antihypertensive Medication, of the Outcome of Pregnancy in Pregnancy-Associated Hypertension. Kidney & Blood Pressure Research. 24(2). 124–128. 3 indexed citations
7.
Mooij, J. M. V., et al.. (1997). Hypertension in pregnancy: presentation, management and outcome - a retrospective analysis of 135 cases.. PubMed. 43(4). 416–24. 3 indexed citations
8.
Mooij, J. M. V., et al.. (1996). Pulmonary capillary leak syndrome associated with the use of intravenous cyclosporin. Nephrology Dialysis Transplantation. 11(11). 2342–2343. 1 indexed citations
9.
Mooij, J. M. V., et al.. (1996). Commercial living-nonrelated renal transplantation: observations on early complications.. PubMed. 28(3). 1941–4. 7 indexed citations
10.
Mooij, J. M. V., et al.. (1994). Observations in a Saudi-Arabian dialysis population over a 13-year period. Nephrology Dialysis Transplantation. 9(8). 1072–1076. 24 indexed citations
11.
Baak, Marleen A. van & J. M. V. Mooij. (1994). Effect of glucose infusion on endurance performance after beta-adrenoceptor blocker administration. Journal of Applied Physiology. 77(2). 641–646. 7 indexed citations
12.
Baak, Marleen A. van, J. M. V. Mooij, & Jannie P. Wijnen. (1993). Effect of Increased Plasma Non-Esterified Fatty Acid Concentrations on Endurance Performance During Beta-Adrenoceptor Blockade. International Journal of Sports Medicine. 14(1). 2–8. 15 indexed citations
13.
Mooij, J. M. V., et al.. (1993). Cyclosporine in the treatment of lupus nephritis including two patients treated during pregnancy.. PubMed. 40(3). 160–3. 41 indexed citations
14.
Baak, Marleen A. van, J. M. V. Mooij, & Paul Schiffers. (1992). Exercise and the pharmacokinetics of propranolol, verapamil and atenolol. European Journal of Clinical Pharmacology. 43(5). 547–550. 10 indexed citations
15.
Baak, Marleen A. van, et al.. (1991). Submaximal endurance exercise performance during enalapril treatment in patients with essential hypertension. Clinical Pharmacology & Therapeutics. 50(2). 221–227. 9 indexed citations
16.
Joosten, Jan, et al.. (1991). Nebivolol in Hypertensive Patients. Clinical Drug Investigation. 3(S1). 105–106. 2 indexed citations
17.
Schiffers, Paul, et al.. (1991). Invasive Haemodynamics of Nebivolol in Hypertensive Patients. Clinical Drug Investigation. 3(S1). 60–60. 2 indexed citations
18.
Bortel, L.M.A.B. Van, et al.. (1990). The influence of chronic treatment with verapamil on plasma atrial natriuretic peptide levels in young and elderly hypertensive patients. European Journal of Clinical Pharmacology. 39(1). S39–S40. 2 indexed citations
19.
Merode, Tiny Van, et al.. (1990). The Effect of Verapamil on Carotid Artery Distensibility and Cross-Sectional Compliance in Hypertensive Patients. Journal of Cardiovascular Pharmacology. 15(1). 109–113. 17 indexed citations
20.
Merode, Tiny Van, et al.. (1989). Verapamil and nebivolol improve carotid artery distensibility in hypertensive patients. Journal of Hypertension. 7(6). S262–263. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adam Rahman Breakdown of academic impact, for papers by László Asztalos Breakdown of academic impact, for papers by L. R. Solomon Breakdown of academic impact, for papers by Elliott Savdie Breakdown of academic impact, for papers by Robert B. Dorman Breakdown of academic impact, for papers by Gilad Hamdani Breakdown of academic impact, for papers by Daad H. Akbar Breakdown of academic impact, for papers by Shinobu Sugihara Breakdown of academic impact, for papers by Joana Silvestre Breakdown of academic impact, for papers by Duff Jh
Rankless by CCL
2026